The DOI matches its Crossref record; 63 of the 63 references it cites were found in a registry or an index.
The MicroArray Quality Control (MAQC)-II study of common practices for the development and validation of microarray-based predictive models
Open accessAbstract
Gene expression data from microarrays are being applied to predict preclinical and clinical endpoints, but the reliability of these predictions has not been established. In the MAQC-II project, 36 independent teams analyzed six microarray data sets to generate predictive models for classifying a sample with respect to one of 13 endpoints indicative of lung or liver toxicity in rodents, or of breast cancer, multiple myeloma or neuroblastoma in humans. In total, >30,000 models were built using many combinations of analytical methods. The teams generated predictive models without knowing the biological meaning of some of the endpoints and, to mimic clinical reality, tested the models on data that had not been used for training. We found that model performance depended largely on the endpoint and team proficiency and that different approaches generated models of similar performance. The conclusions and recommendations from MAQC-II should be useful for regulatory agencies, study committees and independent investigators that evaluate methods for global gene expression analysis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Using the common intra-site DEGs to validate the called inter-site DEGs, the MCC41, 42 showed that PEER also yields a higher accuracy than the original limmavoom method (Supplementary Fig. 22d,e), indicating that global data normalization analysis methods such as PEER can also be used to improve RNA-seq data across both Illumina and the PGM platforms.”
From Detecting and correcting systematic variation in large-scale RNA sequencing data (2014) · cites this paper as [42]
In the citing paper
“for instance, the Food and Drug Administration (FDA) agency of the USA employed the MCC as the main evaluation measure in the MicroArray II / Sequencing Quality Control (MAQC/SEQC) projects [41, 42].”
From The advantages of the Matthews correlation coefficient (MCC) over F1 score and accuracy in binary classification evaluation (2020) · cites this paper as [41]
In the citing paper
“Within the MicroArray Quality Control (MAQC)-II study [7], we observed, however, that the performance of gene expression models in predicting clinical outcome was limited and largely dependent on the respective clinical endpoint.”
From Comparison of RNA-seq and microarray-based models for clinical endpoint prediction (2015) · cites this paper as [7]
In the citing paper
“Within the MicroArray Quality Control (MAQC)-II study [7], we observed, however, that the performance of gene expression models in predicting clinical outcome was limited and largely dependent on the respective clinical endpoint.”
From Comparison of RNA-seq and microarray-based models for clinical endpoint prediction (2015) · cites this paper as [7]
In the citing paper
“Considering the fact that the nature of the clinical endpoint strongly affects a classifier’s performance [7, 18], we included endpoints that are known to cover a broad range of predictive difficulties (low difficulty, SEX, and CLASS LABEL; intermediate difficulty, EFS ALL, and OS ALL; high difficulty, EFS HR, and OS HR).”
From Comparison of RNA-seq and microarray-based models for clinical endpoint prediction (2015) · cites this paper as [7]
In the citing paper
“Evaluation of the prediction performances in the validation set revealed that the endpoint represents the most relevant factor affecting model performances, which is well in line with the findings of the MAQC-II study [7].”
From Comparison of RNA-seq and microarray-based models for clinical endpoint prediction (2015) · cites this paper as [7]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gene expression profiling predicts clinical outcome of breast cancer
van 't Veer, L. J., Dai, H., van de Vijver, M. J., He, Y. D., Hart, A. A. M., Mao, M., Peterse, H. L., van der Kooy, K., Marton, M. J., Witteveen, A. T., et al. (2002) · Nature · doi:10.1038/415530a · Cited by 9,536
Unbiased Recursive Partitioning: A Conditional Inference Framework
Hothorn, T., Hornik, K., & Zeileis, A. (2006) · Journal of Computational and Graphical Statistics · doi:10.1198/106186006x133933 · Cited by 4,021
Comparison of Discrimination Methods for the Classification of Tumors Using Gene Expression Data
Dudoit, S., Fridlyand, J., & Speed, T. P. (2002) · Journal of the American Statistical Association · doi:10.1198/016214502753479248 · Cited by 2,671 · cited 1×
“Although previous studies have compared and benchmarked individual steps in the model development proces”
ResultMAQC Consortium, Shi, L., Shi, L., Reid, L. H., Jones, W. D., Shippy, R., Warrington, J. A., Baker, S. C., Collins, P. J., de Longueville, F., et al. (2006) · Nature Biotechnology · doi:10.1038/nbt1239 · Cited by 2,126
Self-citationThat BLUP is a Good Thing: The Estimation of Random Effects
Robinson, G. K. (1991) · Statistical Science · doi:10.1214/ss/1177011926 · Cited by 1,694
Selection bias in gene extraction on the basis of microarray gene-expression data
Ambroise, C., & McLachlan, G. J. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.102102699 · Cited by 1,537 · cited 1×
“, poor data quality and/or insufficient cross-validation of all model development step”
BackgroundDavé, S. S., Wright, G. W., Tan, B. K., Rosenwald, A., Gascoyne, R. D., Chan, W. C., Fisher, R. I., Braziel, R. M., Rimsza, L. M., Grogan, T. M., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa041869 · Cited by 1,417 · cited 1×
“Previously, reanalysis of a widely cited single stud”
BackgroundMicroarray data analysis: from disarray to consolidation and consensus
Allison, D. B., Cui, X., Page, G. P., & Sabripour, M. (2006) · Nature Reviews Genetics · doi:10.1038/nrg1749 · Cited by 1,339
Buyse, M. E., Loi, S., Veer, L. V., Viale, G., Delorenzi, M., Glas, A. M., Saghatchian, M., Bergh, J. C. S., Lidereau, R., Ellis, P., et al. (2006) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djj329 · Cited by 1,238
Shedden, K., Taylor, J. M. G., Misek, D. E., Chang, A. C., Hanash, S., Kuick, R. D., Beer, D. G., Enkemann, S. A., Yeatman, T. J., Eschrich, S. A., et al. (2008) · Nature Medicine · doi:10.1038/nm.1790 · Cited by 1,176
Flagged first, then by citations
Cited by
Sorted by citations
Items 701–800 of 894
Zhao, C., Shi, L. M., Tong, W., Shaughnessy, J. D., Oberthuer, A., Pusztai, L., Deng, Y., Symmans, W. F., & Shi, T. (2011) · BMC Genomics · doi:10.1186/1471-2164-12-s5-s3 · Cited by 2
Statistical Learning in Precision Medicine
Perumbakkam, S. S., & Kohl, M. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-805364-5.00003-2 · Cited by 2
False discovery control for penalized variable selections with high-dimensional covariates
He, K., Zhou, X., Jiang, H., Wen, X., & Li, Y. (2018) · Statistical Applications in Genetics and Molecular Biology · doi:10.1515/sagmb-2018-0038 · Cited by 2
“These data are described in Shaughnessy et al. (2007), and can be obtained through the MicroArray Quality Control Consortium II study (Shi et al., 2010), available on GEO (GSE24080).”
A Multi-objective Meta-Analytic Method for Customer Churn Prediction
Haque, M. N., de Vries, N. J., & Moscato, P. (2019) · Springer eBooks · doi:10.1007/978-3-030-06222-4_20 · Cited by 2
Wang, Z. (2021) · Test · doi:10.1007/s11749-021-00770-2 · Cited by 2
Genomics and Bioinformatics in Biological Discovery and Pharmaceutical Development
Jones, W. D. (2020) · Springer eBooks · doi:10.1007/978-3-030-48555-9_3 · Cited by 2
Lacroix, B., & Citovsky, V. (2013) · F1000Research · doi:10.3410/f1000research.2-33.v1 · Cited by 2
Brain Neural Progenitors are New Predictive Biomarkers for Breast Cancer Hormonotherapy
Basseville, A., Cordier, C., Azzouz, F. B., Gouraud, W., Lasla, H., Panloup, F., Campone, M., & Jézéquel, P. (2022) · Cancer Research Communications · doi:10.1158/2767-9764.crc-21-0090 · Cited by 2
Application of “Omics” Technologies to In Vitro Toxicology
Balmer, N. V., Dao, T., Leist, M., Vojnits, K., Waldmann, T., Zhao, L., Högberg, H. T., & van Vliet, E. (2014) · Methods in pharmacology and toxicology · doi:10.1007/978-1-4939-0521-8_18 · Cited by 2
MicroRNA Microarray Data Analysis in Colon Cancer: Effects of Normalization
López–Campos, G., Romera-López, A., Martin-Sanchez, F. J., Díaz‐Rubio, E., López-Alonso, V., & Pérez‐Villamil, B. (2011) · Lecture notes in computer science · doi:10.1007/978-3-642-21498-1_33 · Cited by 2
“Several works have been done in gene expression analysis with the aim of studying and standardizing the effects of different data analysis techniques and approaches (3, 4 ).”
BackgroundGene Expression Profiling in Pancreatic Cancer
Pilarsky, C. P., & Grützmann, R. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-408103-1.00007-8 · Cited by 2
microRNA Biomarkers as Potential Diagnostic Markers for Cancer
Mambo, E., Szafranska-Schwarzbach, A. E., Latham, G. J., Adai, A. T., Schlageter, A. M., & Andruss, B. F. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-397336-8.00005-7 · Cited by 2
Hu, A., Huang, Z., Liu, P., Tian, X., Shi, Y., & Zhang, L. (2016) · Tumor Biology · doi:10.1007/s13277-016-5449-4 · Cited by 2
Artificial Intelligence: Emerging Applications in Biotechnology and Pharma
Sahner, D., & Spellmeyer, D. C. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-815585-1.00028-0 · Cited by 2
Pathways and Networks as Functional Descriptors for Human Disease and Drug Response Endpoints
Nikolsky, Y., Bessarabova, M., Kirillov, E., Dezső, Z., Shi, W., & Nikolskaya, T. (2011) · doi:10.1002/9783527638079.ch19 · Cited by 2
Why is it so difficult to data mine relevant genome-scale biomarkers?
Azuaje, F. J. (2010) · Expert Opinion on Medical Diagnostics · doi:10.1517/17530059.2011.537654 · Cited by 2
Approximate nonparametric maximum likelihood inference for mixture models via convex optimizationPreprint
Feng, L., & Dicker, L. H. (2016) · arXiv (Cornell University) · doi:10.48550/arxiv.1606.02011 · Cited by 2
Jacob, L., Gagnon-Bartsch, J. A., & Speed, T. P. (2012) · arXiv (Cornell University) · doi:10.14288/1.0043686 · Cited by 2
Choudhry, P., Kasap, C., Patiño-Escobar, B., Gugliemini, O., Geng, H., Sarin, V., Kang, A. S., Kishishita, A., Rampersaud, S., Sarah, L., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.08.04.455165 · Cited by 2
Annotated Compendium of 102 Breast Cancer Gene-Expression DatasetsPreprint
Nwosu, I. O., Tabler, D. D., Chipman, G., & Piccolo, S. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.09.22.559045 · Cited by 2
Inflation of test accuracy due to data leakage in deep learning-based classification of OCT images
Tampu, I. E., Eklund, A., & Haj-Hosseini, N. (2022) · Scientific Data · doi:10.1038/s41597-022-01618-6 · Cited by 1
Davari, A., Islam, S., Seehaus, T., Hartmann, A., Braun, M., Maier, A., & Christlein, V. (2021) · IEEE Transactions on Geoscience and Remote Sensing · doi:10.1109/tgrs.2021.3115883 · Cited by 35
Exploration of the Prognostic Markers of Multiple Myeloma Based on Cuproptosis‐Related Genes
Gao, X., Yuan, J., Zhang, X., Wang, R.-C., Yang, J., Li, Y., & Li, J. (2025) · Cancer Reports · doi:10.1002/cnr2.70151 · Cited by 1
A prognostic model for multiple myeloma based on lipid metabolism related genes.
Li, Z., Zhao, L., Shi, F., Guo, J., & Zhou, W. H. (2025) · PubMed Central · doi:10.11817/j.issn.1672-7347.2025.240592 · Cited by 1
Qu, J., Zhang, M., Hu, Y., Yang, G., Zhang, X., Zhang, W., & Qu, Y.-Q. (2025) · International Journal of Genomics · doi:10.1155/ijog/7060748 · Cited by 1
Hu, M., Luo, Q., Li, J., Chen, Y., Chen, M., Tian, Z., Wei, L., Chen, F., & Zhang, J. (2025) · Scientific Reports · doi:10.1038/s41598-025-21932-4 · Cited by 1
“Based on the average AUC performance across the three datasets (GSE25066, GSE20194, and GSE20271), NNET, RF, BN, and GBM were selected as the base models for final stacking, leading to the construction of the final ensemble model, ENS.”
InfluentialArtificial intelligence in biomarker discovery for diseases: diagnostic and therapeutic prospects
Dinç, R., & Ardıç, N. (2026) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-026-02946-4 · Cited by 1
Ding, F. (2013) · D-Scholarship@Pitt (University of Pittsburgh) · Cited by 1
Mitigating bias in planning two-colour microarray experiments
Ferhatosmanoğlu, N., Allen, T. T., & Çatalyürek, Ü. V. (2015) · International Journal of Data Mining and Bioinformatics · doi:10.1504/ijdmb.2015.070838 · Cited by 1
An adaptive feature selection method for microarray data analysis
Cheng, J., Greshock, J. D., Shi, L. M., Painter, J. L., Lin, X., Lee, K., Zheng, S. S., Wooster, R., Pusztai, L., & Menius, A. (2012) · IEEE International Conference on Bioinformatics and Biomedicine (BIBM) · doi:10.1109/bibm.2012.6392686 · Cited by 1
Genomics Insights: Inter-Laboratory Variability in Array-Based RNA Quantification Methods
Wong, V. Y., & Duval, M. X. (2013) · Genomics Insights · doi:10.4137/gei.s11909 · Cited by 1
Microarray classification with hierarchical data representation and novel feature selection criteria
Bosio, M., Bellot, P., Salembier, P., & Oliveras, A. (2012) · IEEE International Conference on Bioinformatics and Bioengineering (BIBE) · doi:10.1109/bibe.2012.6399648 · Cited by 1
“The metagene creation process induced benefits within this framework too, considerably improving the mean performance with respect to solutions involving only genes.”
BackgroundMethodInfluentialMulticlass cancer-microarray classification algorithm with pair-against-all redundancy
Bosio, M., Bellot, P., Salembier, P., & Oliveras, A. (2012) · IEEE International Workshop on Genomic Signal Processing and Statistics · doi:10.1109/gensips.2012.6507741 · Cited by 1
The Value of Genomic Analysis of Breast Cancer in Drug Development
Székely, B., & Pusztai, L. (2011) · JNCI Monographs · doi:10.1093/jncimonographs/lgr039 · Cited by 1
Genomic Markers for Neuroblastoma Risk Estimation: Superseding Tumor Stage, Age and Mycn?
Oberthuer, A. (2013) · Biomarkers in Medicine · doi:10.2217/bmm.13.97 · Cited by 1
Kohl, M. (2012) · International Journal of Statistics in Medical Research · doi:10.6000/1929-6029.2012.01.01.09 · Cited by 1
Detecting differentially expressed genes by smoothing effect of gene length on variance estimation
Tang, J., & Wang, F. (2015) · Journal of Bioinformatics and Computational Biology · doi:10.1142/s0219720015420044 · Cited by 1
IPA: Integrated predictive gene signature from gene expression based breast cancer patient samples
Saini, A. K., Hou, J., & Zhou, W. (2014) · Deakin Research Online (Deakin University) · Cited by 1
Bioinformatics of Genomics in the Assessment of Cancer
Bushel, P. R. (2016) · Royal Society of Chemistry eBooks · doi:10.1039/9781782624059-00442 · Cited by 1
Molecular-based Testing in Breast Disease for Therapeutic Decisions
Baehner, F. L., & Badve, S. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-0604-8.00010-2 · Cited by 1
geneEx - A Novel Tool to Assess Differential Expression from Gene and Exon Sequencing Data
Scicolone, O. M., Paciello, G., & Ficarra, E. (2018) · International Joint Conference on Biomedical Engineering Systems and Technologies (BIOSTEC) · doi:10.5220/0006657501740181 · Cited by 1
Toxicogenomics and Toxicoinformatics: Supporting Systems Biology in the Big Data Era
de Souza, T. M., Kleinjans, J. C. S., & Jennen, D. G. J. (2019) · Royal Society of Chemistry eBooks · doi:10.1039/9781782623656-00214 · Cited by 1
A bendamustine resistance gene signature in diffuse large B-cell lymphoma and multiple myeloma
Issa, I. I., Brøndum, R. F., Due, H., Schmidt, L., Bøgsted, M., & Dybkær, K. (2020) · Cancer Drug Resistance · doi:10.20517/cdr.2020.76 · Cited by 1
Bayesian multiple Gaussian graphical models for multilevel variables from unknown classes
Lin, J., & Kim, I. (2022) · Statistical Methods in Medical Research · doi:10.1177/09622802211022405 · Cited by 1
Bayesian penalized Buckley-James method for high dimensional bivariate censored regression models
Yin, W., Zhao, S. D., & Liang, F. (2022) · Lifetime Data Analysis · doi:10.1007/s10985-022-09549-5 · Cited by 1
Transcriptome Analysis of Adrenocortical Cells in Health and Disease
Ishii, T. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-819801-8.00017-x · Cited by 1
Artificial Intelligence in Blood Transcriptomics
Warnat‐Herresthal, S., Oestreich, M., Schultze, J. L., & Becker, M. (2021) · Springer eBooks · doi:10.1007/978-3-030-58080-3_262-1 · Cited by 1
Increased expression of CEP72 predicts poor prognosis in multiple myeloma
Guo, D., Lu, J., Ji, H., Lin, Z., Hong, L., Huang, H., & Liu, H. (2023) · International Journal of Laboratory Hematology · doi:10.1111/ijlh.14024 · Cited by 1
Shi, X., Wang, X., Lu, J., Halakivi-Clarke, L., Clarke, R. C., Neuwald, A. F., & Xuan, J. (2025) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1012750 · Cited by 1
“The datasets are part of the MicroArray Quality Control Project (MAQC) project for benchmarking and characterize RNA-seq technology [55,56].”
Ensemble learning and hierarchical data representation for microarray classification
Bosio, M., Bellot, P., Salembier, P., & Oliveras, A. (2013) · IEEE International Conference on Bioinformatics and Bioengineering (BIBE) · doi:10.1109/bibe.2013.6701647 · Cited by 1
Bosio, M., Salembier, P., Bellot, P., & Oliveras, A. (2013) · Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC) · doi:10.1109/embc.2013.6609567 · Cited by 1
Some Additional Tools for the Molecular Biologist
Hoy, M. A. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-415874-0.00006-8 · Cited by 1
Genetic Markers of Endometrial Receptivity
Díaz-Gimeno, P., & García-Velasco, J. A. (2019) · Cambridge University Press eBooks · doi:10.1017/9781108236263.005 · Cited by 1
Piccaluga, P. P. (2019) · Biomedical Journal of Scientific & Technical Research · doi:10.26717/bjstr.2019.15.002638 · Cited by 1
Simultaneous estimation of normal means with side information
Zhao, S. D. (2019) · Statistica Sinica · doi:10.5705/ss.202019.0075 · Cited by 1
Cassidy, J. W. (2020) · IntechOpen eBooks · doi:10.5772/intechopen.93160 · Cited by 3
RNA-Seq Analysis: Methods, Applications and Challenges
vari, A., Geraci, F., Saha, I., & Bianchini, M. (2020) · Frontiers research topics · doi:10.3389/978-2-88963-705-8 · Cited by 1
Minnai, F., Noci, S., Chierici, M., Cotroneo, C. E., Bartolini, B., Incarbone, M., Tosi, D., Mattioni, G., Jurman, G., Dragani, T. A., et al. (2022) · Cancer Science · doi:10.1111/cas.15591
Souihi, N. (2014) · KTH Publication Database DiVA (KTH Royal Institute of Technology) · Cited by 1
In Silico Approaches: Data Management – Bioinformatics
Brandenburg, A., Gmuender, H., & Wittenberger, T. (2014) · Methods and principles in medicinal chemistry · doi:10.1002/9783527674183.ch03 · Cited by 1
Guarding from Spurious Discoveries in High DimensionPreprint
B, J. F. A., & Zhou, W. (2015) · arXiv (Cornell University) · Cited by 1
Biochips: Bright Future in Clinical Dx?
Kohl, M., & Koch, S. (2011) · Journal of Biochips & Tissue Chips · doi:10.4172/2153-0777.s1-e003 · Cited by 1
BNP-Seq: Bayesian Nonparametric Differential Expression Analysis of Sequencing Count DataPreprint
Dadaneh, S. Z., Qian, X., & Zhou, M. (2016) · arXiv (Cornell University) · doi:10.48550/arxiv.1608.03991 · Cited by 1
Computational Biology Approaches to Support Biomarker Discovery and Development
Ли, Б., Shin, H., Trepicchio, W. L., & Dorner, A. J. (2020) · Wiley eBooks · doi:10.1002/9781119187547.ch24 · Cited by 1
Deep learning based multi-batch calibration for classification in various omicsPreprint
Wang, Q., Niu, J., Xu, W. H., Wei, D., & Qian, K. (2021) · Research Square · doi:10.21203/rs.3.rs-1017151/v1 · Cited by 1
Shang, J., Zhao, Y., Jiang, H., Yang, J., Zhang, N., Ren, L., Chen, Q., Yu, Y., Shi, L. M., Chen, H., et al. (2021) · medRxiv · doi:10.1101/2021.12.16.21267913 · Cited by 1
Campbell, G., Li, H., Pennello, G. A., & Yue, L. Q. (2018) · Wiley eBooks · doi:10.1002/9781118445112.stat04944.pub2 · Cited by 1
Elitzur, R., Katz, N., Muttath, P., & Soberman, D. A. (2023) · SSRN Electronic Journal · doi:10.2139/ssrn.4674493 · Cited by 1
A Lung Cancer Mouse Model DatabasePreprint
Cai, L., Gao, Y., DeBerardinis, R. J., Acquaah-Mensah, G. K., Aidinis, V., Beane, J., Biswal, S. S., Chen, T., Concepcion, C. P., Grüner, B. M., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.02.28.582577 · Cited by 1
Pharmacogenetics—Statistical Considerations
Flynn, A. A., Ledgerwood, C., & O’Hare, C. (2015) · Advances in predictive, preventive and personalised medicine · doi:10.1007/978-3-319-15344-5_4
Graphical Displays for Biomarker Data
Zucknick, M., Hielscher, T., Sill, M., & Benner, A. (2012) · Springer eBooks · doi:10.1007/978-1-4614-5329-1_8
Analysis of Array Data and Clinical Validation of Array-Based Assays
Haibe‐Kains, B., & Quackenbush, J. F. (2012) · Springer eBooks · doi:10.1007/978-3-642-28203-4_11
Análisis de datos de Microarrays
Maestre, J. G. (2010)
Detection of Phenotypes in Microarray Data Using Force- Directed Placement Transformss
Perez, D. V., & Robbins, K. A. (2011) · Lecture notes in computer science · doi:10.1007/978-3-642-23199-5_24
CAMDA 2014: Learning from differential expression in the Japanese Toxicogenomic Project
Luuk, H. (2014) · Systems Biomedicine · doi:10.1080/21628130.2015.1010928
Gene Markers Representing Stem Cells and Cancer Cells for Quality Control
Tanabe, S. (2011) · InTech eBooks · doi:10.5772/22663
“…Path Initiative for medical product development is useful to detect gene markers in cells (MAQC Consortium, 2006, 2010; Fan et al., 2010; Oberthuer et al., 2010; Huan et al., 2010; Luo et al., 2008; Parry et al., 2010; Shi et al., 2010; Miclaus et al., 2010; Hong et al., 2010; Tillinghast, 2010).”
BackgroundUse of Toxicogenomics for Mechanistic Characterization of Hepatocarcinogens in Shorter Term Studies
Ellinger-Ziegelbauer, H. C. (2014) · Methods and principles in medicinal chemistry · doi:10.1002/9783527674183.ch06
Meta‐analysis and the multiple testing problem
Galwey, N. W. (2014) · doi:10.1002/9781118861769.ch8
Single-base mismatch profiles for NGS samplesPreprint
Chierici, M., Jurman, G., Roncador, M., & Furlanello, C. (2011) · arXiv (Cornell University) · doi:10.48550/arxiv.1109.1108
Data Mining and Meta-Analysis on DNA Microarray Data
Paparountas, T., Nikolaidou-Katsaridou, M. N., Rustici, G., & Aidinis, V. (2012) · International Journal of Systems Biology and Biomedical Technologies · doi:10.4018/ijsbbt.2012070101
Parry, R. M., Phan, J. H., & Wang, M. D. (2011) · ACM International Conference on Bioinformatics, Computational Biology, and Health Informatics (ACM-BCB) · doi:10.1145/2147805.2147809
Cross platform classification of microarrays by rank comparison
Lee, S. (2015) · Journal of the Korean Data and Information Science Society · doi:10.7465/jkdi.2015.26.2.475
Chung, T., & Chng, W. J. (2012) · International Journal of Hematologic Oncology · doi:10.2217/ijh.12.18
Tong, W., & Fan, X. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-1921
Developing a novel test to detect cancer genes from microarray data
Mathur, S., & Mathur, S. (2014) · International Journal of Bioinformatics Research and Applications · doi:10.1504/ijbra.2014.065246
Predictive markers for chemotherapy response in breast cancer.
Steenkamer, M. (2012) · Utrecht University Repository (Utrecht University)
Histogram based Hierarchical Data Representation for Microarray Classification
Kottath, S. (2012) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Donaires, F. S. (2011) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.17.2011.tde-26092011-111938
Microarray-Based Environmental Diagnostics
Chandler, D. P. (2015) · ASM Press eBooks · doi:10.1128/9781555818821.ch2.3.3
Mathematisch-naturwissenschaftlichen Fakultät, I. (2012)
Maretty, L., Sibbesen, J. A., & Krogh, A. (2014)
Multivariate Synergies in Pharmaceutical Roll Compaction
Souihi, N. (2014)
Data Integration Methods to Interpret Genome-Scale Data from Cancers
Laakso, M. (2012) · Työväentutkimus Vuosikirja
Sanavia, T. (2012) · Institutional Research Information System University of Turin (University of Turin)
Cifuentes, M. P., Doogan, N., Fernández, S., & Seiber, E. E. (2016) · Journal of Policy Modeling · doi:10.1016/j.jpolmod.2016.03.014
RetractedGravitropic Signal Transduction: A Systems Approach to Gene Discovery
Shen, K. (2014) · OhioLink ETD Center (Ohio Library and Information Network)
D-trace Precision Matrix Estimation Using Adaptive Lasso PenaltiesPreprint
Nogales, F. J., Alonso, A. M., & Avagyan, V. (2015) · RePEc: Research Papers in Economics
Mathematical Assessment of Prognosis
Reme, T. X., & Klein, B. (2013) · Journal of Applied Bioinformatics & Computational Biology · doi:10.4172/2329-9533.1000102
“This has been early emphasized by the MicroArray Quality Control studies, anticipating that a good predictor can present a strong and reproducible statistical value without necessarily explaining biological diversity [5].”
Background
Metadata
- Authors
- MAQC Consortium
- Venue
- Nature Biotechnology
- Published
- 2010-07-30
- Volume
- 28
- Issue
- 8
- Pages
- 827-838
- ISSN
- 0733-222X (ISSN-L)
- 1087-0156
- 1546-1696
- PMC
- PMC3315840
- OpenAlex
- W2021560851
- Cited by
- 889
- References
- 63
- Citations by year
- 2026: 13 · 2025: 33 · 2024: 39 · 2023: 35 · 2022: 40 · 2021: 58 · 2020: 61 · 2019: 58 · 2018: 46 · 2017: 35 · 2016: 57 · 2015: 54 · 2014: 87 · 2013: 85 · 2012: 79
- FWCI
- 34.94
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Nature Biotechnology (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles) (submittedVersion)
- Infoscience (Ecole Polytechnique Fédérale de Lausanne) (submittedVersion)
- Infoscience (Ecole Polytechnique Fédérale de Lausanne) (submittedVersion, cc-by-nc-nd)
- Institute of Process Engineering, CAS Institutional Repository (submittedVersion, cc-by-nc-sa)
- IRIS (submittedVersion)
- Repository of Futwangen University of Applied Sciences (Furtwangen University) (submittedVersion)
- SERVAL (Université de Lausanne) (submittedVersion)
- Funders
- National Institutes of Health (Z99 LM999999, Z99 HL999999, Z99 MH999999, Z99CL999999)
- National Cancer Institute (CA97513-01, CA55819-01A1, R00CA126184, P01CA055819, R33CA097513)
- National Institute of General Medical Sciences (T32GM074906, R01GM083084, R01GM083226, R01GM072611)
- National Center for Research Resources (R01RR021967)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gene expression and cancer classification
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Breast Cancer Treatment Studies
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods
- Keywords
- microarray quality control, gene expression profiling, prediction model, genomic classifier, model validation, pulmonary toxicity, hepatotoxicity, breast cancer, multiple myeloma, neuroblastoma, rodent toxicity, method comparison, reproducibility
- MeSH terms
- Animals, Breast Neoplasms, Disease Models, Animal, Female, Humans, Liver Diseases, Lung Diseases, Multiple Myeloma, Neoplasms, Neuroblastoma, Predictive Value of Tests, Quality Control, Survival Analysis, Guidelines as Topic, Oligonucleotide Array Sequence Analysis, Gene Expression Profiling, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
